RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
Increasing evidence suggests a pivotal role of receptor-interacting protein kinase 1 (RIPK1), an initiator of necroptosis, in neuroinflammation. However, the precise role of RIPK1 in microglial activation remains unclear. In the present study, we explored the role of RIPK1 in lipopolysaccharide (LPS...
Main Authors: | Do-Yeon Kim, Yea-Hyun Leem, Jin-Sun Park, Jung-Eun Park, Jae-Min Park, Jihee Lee Kang, Hee-Sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/3/417 |
Similar Items
-
Necrostatin-1 Prevents Ferroptosis in a RIPK1- and IDO-Independent Manner in Hepatocellular Carcinoma
by: Hanna Yuk, et al.
Published: (2021-08-01) -
The Role of RIPK1 and RIPK3 in Cardiovascular Disease
by: Elise DeRoo, et al.
Published: (2020-10-01) -
The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
by: Pauline Puylaert, et al.
Published: (2022-04-01) -
The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases
by: Longhuan Piao, et al.
Published: (2023-05-01) -
The phospho-barcode of RIPK1: complementarity or redundancy?
by: Wenxian Wu, et al.
Published: (2020-09-01)